MOTS-c acts as a mitokine, a signaling molecule released by mitochondria that communicates with the nucleus and other parts of the cell
BPC-157 supports this interconnected system by: Strengthening tight junctions between intestinal epithelial cells, reducing intestinal permeability (leaky gut) Modulating the enteric nervous system to normalize motility and reduce visceral hypersensitivity Regulating mucosal immune responses to prevent inappropriate inflammation against dietary and microbial antigens Conditions Treated with Oral BPC-157 Beyond Symptom Relief: Addressing Root Causes Unlike proton pump inhibitors (PPIs) that suppress stomach acid or corticosteroids that broadly dampen immunity, BPC-157 works by restoring the underlying structural and functional integrity of the gastrointestinal tract
This is not a one-size-fits-all approach
MedlineWeb of Science Kalyoncu U, Buyukasik Y, Akdogan A, Karadag O, Bilgen SA, Kiraz S, et al
Synthetic peptides can be altered to persist longer in blood or to target specific tissues by attaching small chemical moieties or cyclizing the chain to prevent degradation
Never double up doses to make up for a missed injection